Physician profile
Wayne C Berg
NPI 1851813299
$3,406.93
in general payments reported to CMS, 2019-2025
26 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $826 · 2022: $790 · 2023: $721 · 2024: $592 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,627.23 |
| Education | $164.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $689.18 | 2021-2024 | Xiaflex, Aveed |
| Astellas Pharma US INC | $584.39 | 2021-2025 | Veozah |
| Sumitomo Pharma America, INC. | $485.15 | 2023-2025 | Gemtesa |
| Endo USA, INC. | $313.19 | 2024-2025 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $218.82 | 2021-2025 | Erleada |
| Abbvie INC. | $214.41 | 2021-2025 | |
| Medtronic, INC. | $142.40 | 2024-2025 | Interstim |
| Antares Pharma, INC. | $88.37 | 2021-2022 | |
| Myovant Sciences INC. | $72.08 | 2021-2022 | |
| Allergan, INC. | $66.98 | 2021-2022 | |
| 180 Medical, INC. | $66.94 | 2022-2023 | |
| Teleflex LLC | $63.45 | 2021 | |
| Travere Therapeutics, INC. | $58.83 | 2022 | |
| Myriad Genetic Laboratories, INC. | $52.58 | 2021-2024 | Myrisk |
| Pfizer INC. | $46.52 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $37.95 | 2022-2024 | Bulkamid |
| Urovant Sciences INC | $36.68 | 2022 | |
| Urogen Pharma, INC. | $25.04 | 2024 | |
| Ferring Pharmaceuticals INC. | $22.18 | 2024 | Adstiladrin |
| Amgen INC. | $22.12 | 2021 | |
| Laborie Medical Technologies Corp. | $22.11 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Halozyme INC | $18.16 | 2023 | |
| Boston Scientific Corporation | $16.63 | 2024 | Rezum Generator |
| Kowa Pharmaceuticals America, INC. | $14.51 | 2023 | Seglentis |
| Coloplast Corp | $14.29 | 2022 | |
| Clarus Therapeutics INC. | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.